CORONAVIRUS INFO PROVIDED BY DR. JIM HARRIS – 04/24/2021

HELLO, HAVE A NICE WEEKEND

THIS IS PFIZER VACCINE. WALK IN. NO EXCUSE NOT TO GET VACCINATED NOW. 16 YEARS OLD AND UP

THANK YOU ETBU. J. Harris

FROM SOUTHWESTERN MEDICAL SCHOOL: VACCINATION PREVENTS ALMOST ALL OF COVID! WOW

Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center

:… the percentages of persons who became infected differed according to vaccination status, with infections in

1. 234 of 8969 nonvaccinated employees — 2.61%

2. 112 of 6144 partially vaccinated employees —1.82%

3. 4 of 8121 fully vaccinated employees — 0.05%

SUGGESTED BY HOPKINS:

1. We know a lot about Covid-19. Experts have many more questions

(J. Harris: A provocative and readable article that answers some questions and asks more — questions that are of special interest to the researchers.)

2. Saliva As a Gold-standard Sample for SARS-CoV-2 Detection (Lancet Respiratory Medicine) The gold-standard sample for SARS-CoV-2 detection defaulted to the nasopharyngeal swab because of its role in detection of other upper respiratory tract pathogens. Demand for swabs drove a cascading collapse of supply chains and worsened shortages of personal protective equipment (PPE) required by health-care workers for sample collection. As the need for mass testing and frequent, repeated sampling surged, the urgency for alternative sample types became apparent.

3. CureVac’s Shot Could Arrive Just in Time (Bloomberg) Help, however, may be on the way. German biotech company CureVac, which has worked on mRNA technology for two decades, is on the cusp of delivering data from its Covid shot’s 40,000-person late-stage clinical trial. While rivals BioNTech/Pfizer and Moderna raced ahead with trials last year, allowing for eye-popping data to emerge by November, CureVac took a slower approach.

4. Here’s How Scientists are Designing Vaccines that Can Ditch the Fridge (Science): From the cutting-edge vaccines for COVID-19 to the decades-old ones for poliovirus, most vaccines need to be kept cold to survive the trip from factory to patient. But that poses a major hurdle to even routine immunizations in countries like Mali or Bangladesh, where up to 90% of health facilities lack adequate refrigeration. To solve this problem, some researchers are working toward a radical goal: vaccine formulations that don’t have to be kept cold. Significant hurdles remain, but many scientists are optimistic that 10 years from now vaccination campaigns won’t be quite so hampered by the heat.

AND LAST AND NOT LEASED:

The early bird may get the worm, but the second mouse gets the cheese.